993 related articles for article (PubMed ID: 34646151)
1. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
Front Physiol; 2021; 12():715506. PubMed ID: 34646151
[TBL] [Abstract][Full Text] [Related]
2. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
4. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
5. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
6. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
7. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
[TBL] [Abstract][Full Text] [Related]
8. Microbiome and metabolome in inflammatory bowel disease.
Upadhyay KG; Desai DC; Ashavaid TF; Dherai AJ
J Gastroenterol Hepatol; 2023 Jan; 38(1):34-43. PubMed ID: 36287112
[TBL] [Abstract][Full Text] [Related]
9. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
Gonçalves P; Araújo JR; Di Santo JP
Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
11. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
[TBL] [Abstract][Full Text] [Related]
12. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
13. Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.
Banfi D; Moro E; Bosi A; Bistoletti M; Cerantola S; Crema F; Maggi F; Giron MC; Giaroni C; Baj A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562721
[TBL] [Abstract][Full Text] [Related]
14. Host-microbial Cross-talk in Inflammatory Bowel Disease.
Nagao-Kitamoto H; Kamada N
Immune Netw; 2017 Feb; 17(1):1-12. PubMed ID: 28261015
[TBL] [Abstract][Full Text] [Related]
15. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and inflammatory bowel disease.
Chen L; Wang J
WIREs Mech Dis; 2022 Mar; 14(2):e1540. PubMed ID: 35266651
[TBL] [Abstract][Full Text] [Related]
17. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
Henson MA; Phalak P
BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051
[TBL] [Abstract][Full Text] [Related]
18. The Microbiome in Patients With Inflammatory Diseases.
Somineni HK; Kugathasan S
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):243-255. PubMed ID: 30196163
[TBL] [Abstract][Full Text] [Related]
19. The Gut Microbiome and Inflammatory Bowel Diseases.
Shan Y; Lee M; Chang EB
Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of short-chain fatty acids in inflammatory bowel disease.
Zhang Z; Zhang H; Chen T; Shi L; Wang D; Tang D
Cell Commun Signal; 2022 May; 20(1):64. PubMed ID: 35546404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
